Hepatobiliary and Pancreatic Tumor Imaging Course for Radiologists
The ARRS Hepatobiliary and Pancreatic Tumor Imaging Course 2022 is a hepatobiliary and pancreatic tumor imaging course produced by ARRS, delivered as 8 videos plus 2 reference PDFs (621.90MB). Coverage spans dual-energy CT and novel MRI technique, clinical updates on gallbladder and biliary tumors, the diagnostic challenge of primary sclerosing cholangitis, and a case-based review of HPB tumors.
-
8Videos
-
2PDF Files
-
2022Edition
Inside this resource
Advanced Imaging Techniques for HPB Tumors
The course opens with practical tips on the use of dual-energy CT and novel MRI techniques as tools for hepatobiliary and pancreatic tumor imaging.
Biliary Tumor & Cholangitis Updates
Recent clinical updates on gallbladder and biliary tumors are discussed, along with the diagnostic challenge of evaluating patients with primary sclerosing cholangitis.
Case-Based HPB Tumor Review
The course closes with a case-based review of hepatopancreaticobiliary (HPB) tumors, highlighting key teaching points from the session.
Who this serves
- Radiologists and abdominal imaging specialists — the course covers dual-energy CT and MRI technique for interpreting liver, pancreatic, and biliary tumors.
- Radiologists evaluating complex hepatobiliary disease — sessions specifically address the diagnostic challenge of primary sclerosing cholangitis alongside biliary tumor imaging.
Before you buy
What does the course include?
8 videos plus 2 PDFs (621.90MB total) covering dual-energy CT, novel MRI techniques, biliary tumor updates, and a case-based HPB tumor review.
How long are CME credits valid?
Credits were issued October 17, 2022 and expire October 16, 2025.
The chart
| Format | Video course + reference PDFs |
|---|---|
| Duration | 8 videos + 2 PDFs · 621.90 MB |
| Year | 2022 |
| Publisher | ARRS |
| Department | Radiology |
| Delivery | Instant download after checkout · lifetime re-access |
Verified original fileInstant downloadEncrypted checkout



Reviews
There are no reviews yet.